Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07085351 · ClinicalTrials.gov registry record
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
A clinical trial of Opiod Use Disorder, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT07085351: Recruiting study of Opiod Use Disorder, sponsored by University of Illinois at Chicago.
NCT07085351 is a study of Opiod Use Disorder that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07085351, a study of Opiod Use Disorder, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The US is suffering from a national opioid epidemic characterized by significant costs, overdoses, and deaths. Conventional Opioid Use Disorder (OUD) treatments (i.e., pharmacological and psychosocial interventions) are characterized by limited or diminishing efficacy, ceiling effects, and/or serious side effects. The availability of validated OUD biomarkers would be a key step in the development and approval of better treatments. Ultimately, the scarcity of OUD biomarkers represents a significant unmet need in the fight against opioid addiction as recognized by NIDA and the FDA with their support for development of Medical Device Development Tools (MDDT) and biomarker tests for OUD. Advances in neuroimaging techniques, and in particular recent evidence supports electroencephalography (EEG) as a promising candidate to investigate the correlation between addiction and brain state. To address the clear medical and market need for OUD biomarkers, this is a feasibility study to identify and assess potential EEG biomarkers for OUD diagnoses, disease monitoring, and prediction of OUD treatment response.
Primary Outcome
High-density electroencephalogram power will be assessed during rest (eyes open, eyes closed) and activity
Conditions Studied
Study Locations (1)
Illinois
- Clinical & Imaging Research Outcomes Lab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-02-04 |
| Est. Completion | 2025-09-15 |
What NCT07085351 shows while recruiting
NCT07085351 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 1 condition, with Opiod Use Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT07085351 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07085351 about?
NCT07085351 is a clinical study titled "EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications". The US is suffering from a national opioid epidemic characterized by significant costs, overdoses, and deaths. Conventional Opioid Use Disorder (OUD) treatments (i.e., pharmacological and psychosocial interventions) are characterized by limited or diminishing efficacy, ceiling effects, and/or seriou...
What is the current status of trial NCT07085351?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2025-02-04. Estimated completion is 2025-09-15.
What conditions does trial NCT07085351 study?
This clinical trial studies the following conditions: Opiod Use Disorder.
Who is sponsoring clinical trial NCT07085351?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07085351 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiod Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI